Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Fernando Vale

Neurological Surgery Augusta, GA Medical Doctor

NPI 1710906052 CMS profile 213081

1120 15Th St, Augusta, GA 30912

Open in the dashboard

General payments

$67,406

256 records reported · program years 2019–2025

Research payments

$6,105

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$92,230 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Fernando Vale of Augusta, GA is reported in the CMS Open Payments database as having received $67,406 across 256 general payments and $6,105 in research payments paid to them. Separately, studies naming them as principal investigator received $92,230 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 89th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $17,922 62
2024 General $14,947 65
2023 General $8,466 27
2022 General $3,336 40
2021 General $3,664 24
2020 General $750 12
2020 Research $6,105 1
2019 General $18,321 26

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Fernando Vale
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Fernando Vale were reported at $17,922. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Fernando Vale Neurological Surgery median Middle half National median
2019 $18,321 $582 $138–$3,006 $163
2020 $750 $294 $76–$2,174 $114
2021 $3,664 $387 $105–$2,432 $132
2022 $3,336 $542 $139–$2,989 $149
2023 $8,466 $534 $145–$2,697 $160
2024 $14,947 $574 $155–$3,046 $164
2025 $17,922 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. LivaNova USA, Inc. $38,504 81 payments
  2. Integra LifeSciences Corporation $15,787 10 payments
  3. Ethicon Inc. $4,680 2 payments
  4. Medtronic, Inc. $2,852 37 payments
  5. Boston Scientific Corporation $1,651 46 payments
  6. Zimmer Biomet Holdings, Inc. $449 6 payments
  7. Stryker Corporation $426 9 payments
  8. 4WEB, Inc. $331 3 payments
  9. Abbott Laboratories $283 3 payments
  10. NeuroPace, Inc. $245 5 payments
  11. Other $2,198 54 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $33,588 8 payments
  2. Travel and Lodging $16,282 35 payments
  3. Food and Beverage $9,325 208 payments
  4. Consulting Fee $8,180 4 payments
  5. Education $31 1 payment
Products named General payments · program years 2019–2025
  1. VNS THERAPY SENTIVA MODEL 1000 GENERATOR Neurology $18,770 28 payments
  2. DURASEAL EXACT $15,662 7 payments
  3. CUSA CLARITY $15,536 6 payments
  4. CODMAN HAKIM PRECISION VALVE $15,536 6 payments
  5. CODMAN CERTAS $15,536 6 payments
  6. VNS Therapy Neurology $11,498 31 payments
  7. VNS THERAPY SENTIVA MODEL 1000 GENERATOR Cardiology/Vascular Diseases $5,878 14 payments
  8. VISTASEAL $4,680 2 payments
  9. PERCEPT PC BRAINSENSE $2,526 25 payments
  10. VNS Therapy Cardiology/Vascular Diseases $1,933 2 payments
  11. Other $6,741 141 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic USA, Inc. $6,105 1 payment

Billing to Medicare

Part B · data year 2024 · 22 billing codes

Paid by Medicare

$41,792

Medicare's payments for the services billed

Medicare patients

64

Average age 70

Services billed

94

30 women, 34 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 69%
Arthritis 44%
Depression 38%
Diabetes 30%
Ischemic heart disease 23%
Atrial fibrillation 19%
Chronic kidney disease 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

4 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ULTOMIRIS
$63 — —
Austedo XR
$42 — —
RADICAVA
$12 — —
Radicava ORS
$12 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

257 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record